ONCODESIGN PRECISION MEDICINE

Press Releases Oncodesign Precision Medicine

Equities

ALOPM

FR001400CM63

Market Closed - Euronext Paris Other stock markets 06:05:13 23/05/2024 pm IST			5-day change	1st Jan Change
1.245 ^EUR	+0.40%		-4.23%	-31.22%

15/05	Oncodesign Precision Medicine and Navigo Proteins GmbH Sign A Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents	CI
25/01	Oncodesign Precision Medicine: fundraising on the horizon	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncodesign Precision Medicine and Navigo Proteins GmbH Sign a Strategic Collaboration Agreement for the Research and Development of New Systemic Radiotherapy Agents	15/05	BU
Degroof Petercam Initiates Coverage of Oncodesign Precision Medicine	18/04	BU
Oncodesign Precision Medicine (OPM) obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101	17/04	BU
OPM Publishes Its Annual Results for 2023 and Provides an Update on Its Clinical Developments	26/03	BU
Oncodesign Precision Medicine : OPM publishes its annual results for 2023 and provides an update on its clinical developments	26/03	PU
Oncodesign Precision Medicine : OPM announces its 2022 results	13/23/13	PU
Oncodesign Precision Medicine : OPM announces the initiation of Phase I of ODS-101	09/23/09	PU
The General Meeting of Oncodesign authorises the allocation of Oncodesign Precision Medicine shares to Oncodesign shareholders	03/22/03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer